ArisGlobal's COVID-19 Response

Our entire team is ready to continue servicing all customers without interruption, committing to providing exceptional support and customer satisfaction, even in times of uncertainty.

India's Largest Biotech Selects LifeSphere eTMF

The largest biopharmaceutical company in India that enables access to high quality, advanced therapies for chronic diseases, has selected LifeSphere® eTMF as its electronic trial master file system.

Luye Pharma Selects LifeSphere® Signal and Risk Management

Luye Pharma, a pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, has selected LifeSphere as its next-generation signal detection tool.


A Look Back at Partnerships in Clinical Trials Europe

By Danilo Pavlovic As both a conference attendee and ArisGlobal representative in our booth on the show floor at the recent Partnerships in Clinical Trials Europe, I had plenty of opportunity to sit in on sessions, talk to industry colleagues...

read more

CRO, R&D trends

CRO industry grows as increasingly complex R&D trends demand advanced expertise Among today’s CRO, R&D trends, precision-based medicines and immunotherapies for smaller populations and treatments for rare diseases are driving...

read more

What is Really Required in a Modern EDC?

I wrote a post a couple of months ago about the drawbacks of accessing multiple data sources. I discussed how it was essential for project managers to have the available technology, designed for usability that enables them to have the necessary visibility of their...

read more

The Challenge with Today’s Clinical Analytic Platforms

In today’s fast paced ‘all or nothing’ innovative solution-focused industry, clinical software repositories and data analytic solutions for data conformance tend to be complex and miles away from empowering the user with flexibility and ease of use. Time after time,...

read more

10 Life Sciences Companies Switch to ArisGlobal’s LifeSphere® MultiVigilance from Competing Safety Systems

ArisGlobal is proud to announce that ten life sciences companies have switched to its industry-leading LifeSphere® MultiVigilance drug safety system within the past 12 months. LifeSphere MultiVigilance is a next-generation, end-to-end safety system that has been developed in close partnership with industry leaders, including the FDA, Boehringer Ingelheim, Teva and AbbVie, among others.

read more